Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure
| Overview / Abstract: |
Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist. Navigate through this interactive self-directed CME activity to apply the most recent clinical trial data and guidance to patient-specific factors seen in real-world practice. Expert perspectives and available evidence will help you implement GDMT in practice to improve patient quality of life, prevent rehospitalization, and reduce mortality risks in your patients with HF. |
|
Expiration |
Jul 14, 2024 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
1.5 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
AMA PRA Category 1 Credit, MIPS improvement activity |
|
Presenters / Authors / Faculty |
Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA, FACP Nihar R. Desai, MD, MPH |
|
Sponsors / Supporters / Grant Providers |
Supported by independent medical educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company. |
|
Keywords / Search Terms |
ACHL Heart failure, HF, cardiology, American Heart Association, AHA, cardiovascular, CME, continuing medical education, B‐type natriuretic peptide, BNP, N‐terminal pro‐B‐type natriuretic peptide, NT‐proBNP, beta-blocker, MRA, ARNI, and an SGLT2 inhibitor, cardiologists, clinical nurse specialist, hospitalists, internists, primary care providers Free CE CME |
|